Black Rock Inc. Alkermes Plc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Black Rock Inc. holds 29,107,548 shares of ALKS stock, worth $812 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,107,548
Previous 29,168,481
0.21%
Holding current value
$812 Million
Previous $790 Million
11.16%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
361Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Vanguard Group Inc Valley Forge, PA19MShares$529 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$363 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$353 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$256 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.65MShares$186 Million2.97% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.58B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...